Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

ACADIA Pharmaceuticals: Clinical Trials & FDA Approval Profile

ACADIA Pharmaceuticals (Global / Institutional) sponsors 22 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 5 active protocols (5 recruiting now), 10 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)31.8%
Median Closed Enrollment vs National (145 pts)187 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for ACADIA Pharmaceuticals
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)22
Active Pipeline (Recruiting Now)5 (5)
Completed vs Stopped Early10 / 7 (31.8%)
Median Closed Actual Enrollment187 participants
Physical Hospital Site Disclosure99.6% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With ACADIA Pharmaceuticals
Hospital Research SiteLocationShared Protocols
Vanderbilt University Medical CenterNashville, TN6
Washington University and Siteman Cancer CenterSaint Louis, MO5

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by ACADIA Pharmaceuticals
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07095465Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia PsychosisPhase IIIRECRUITING
NCT07029581Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia PsychosisPhase IIRECRUITING
NCT07284667ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant ResponsePhase IIRECRUITING
NCT06159673ACP-204 in Adults With Alzheimer's Disease PsychosisPhase II/IIIRECRUITING
NCT04181723Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)Phase IIICOMPLETED

Explore interactive annual charts and M&A subsidiary rollups in the ACADIA Pharmaceuticals Interactive Dossier, benchmark peers in Neurology, Psychiatry, and Pain, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI